HIV/AIDS and Women's Health in Uganda: Lingering Gender Inequity

Journal of Obstetrics and Gynaecology Canada

Volumn 28, Issue 11, 2006, Pages 980-982

  Okong, Pius ^a  

^a St Francis Hospital Uganda   (Uganda)

Author keywords

Gender; HIV AIDS; Uganda; Women's health

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EPIDEMIC; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; POPULATION GROWTH; PREGNANT WOMAN; SCREENING; SENTINEL SURVEILLANCE; SEROPREVALENCE; SEX RATIO; SOCIAL PARTICIPATION; UGANDA; VERTICAL TRANSMISSION; WOMEN'S HEALTH; DISEASE TRANSMISSION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; REVIEW; SEX DIFFERENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HIV INFECTIONS; HUMANS; MALE; SEX FACTORS; UGANDA; WOMEN'S HEALTH;

EID: 36048979089     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32306-4     Document Type: Article

References (24)

1. Mugerwa R.D., Marum L.H., Serwadda D Human immunodeficiency virus and AIDS in Uganda. East Afr Med J 1996, 73(1):20-26.
2. Wawer M.J., Sewankambo N.K., Serwadda D., Quinn T.C., Paxton L.A., Kiwanuka N., et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999, 353(9152):525-535.
3. Grosskurth H., Gray R., Hayes R., Mabey D., Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000, 355(9219):1981-1987.
4. Burns D.N., Nourjah P., Minkoff H., Korelitz J., Biggar R.J., Landesman S., et al. Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. AmJ Obstet Gynecol 1996, 174(5):1461-1468.
5. Immunological markers in HIV-infected pregnant women. The European Collaborative Study and the Swiss HIV Pregnancy Cohort. AIDS 1997, 11(15):1859-1865.
6. Ahmed Y., Mwaba P., Chintu C., Grange J.M., Ustianowski A., Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis 1999, 3(8):675-680.
7. Coutsoudis A., Coovadia H., Pillay K., Kuhn L. Are HIV-infected women who breastfeed at increased risk of mortality? AIDS 2001, 15(5):653-655.
8. Wabwire-Mangen F., Gray R.H., Wawer M.J., Sewankambo N., Serwadda D. HIV-1 infection and malaria parasitaemia. Lancet 2001, 357(9251):233.
9. HIV/AIDS Surveillance Report, STD/AIDS Control Programme 2003, Uganda Ministry of Health, Kampala, Uganda, June.
10. Borgdorff M., Barongo L., van Jaarsveld E., Klokke A., Senkoro K., Newell J., et al. Sentinel surveillance for HIV-1 infection: how representative are blood donors, outpatients with fever, anaemia, or sexually transmitted diseases, and antenatal clinic attendees in Mwanza Region, Tanzania? AIDS 1993, 7(4):567-572.
11. Gray R.H., Wawer M.J., Serwadda D., Sewankambo N., Li C., Wabwire-Mangen F, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998, 351(9096):98-103.
12. Sperling R.S., Shapiro D.E., Coombs R.W., Todd J.A., Herman S.A., McSherry G.D. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996, 335(22):1621-1629.
13. Mauskopf A., Paul J.E., Wichman D.S., White A.D., Tilson H.H. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening. JAMA 1996, 276(2):132-138.
14. Guay L.A., Musoke P., Fleming T., Bagenda D., Allen M., Nakabiito C., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999, 354(9181):795-802.
15. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomized, double-blind, placebo-controlled trial. Lancet 2002, 359(9313):1178-1186.
16. Weidle P.J., Malamba S., Mwebaze R., Sozi C., Rukundo G., Downing R., et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 2002, 360(9326):34-40.
17. Uganda HIV/AIDS Sero-Behavioral Survey 2004-05. Kampala, Uganda:Uganda Ministry of Health.
18. Dabis F., Ekpini E.R. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002, 359(9323):2097-2104.
19. The MTCT-Plus Initiative. Mailman School of Public Health, Columbia University 2003.
20. World Health Organization. 3 by 5, progress report. World Health Organization 2005, June.
21. Uganda Ministry of Health. Brief on antiretroviral therapy provision in Uganda 2005, Ministry of Health, Kampala, Uganda.
22. Tuomala R.E., Shapiro D.E., Mofenson L.M., Bryson Y., Culnane M., Hughes M.D., et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002, 346(24):1863-1870.
23. Uganda National Council for Children. 1994. Equity and vulnerability: a situation analysis of women, adolescents, and children in Uganda 1994, Government of Uganda: Uganda National Council for Children, Kampala.
24. Kisekka M.N. AIDS in Uganda as a gender issue. Women Ther 1990, 10(3):35-53.